Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children.

Pediatrics

Volumn 108, Issue 2, 2001, Pages

  Luce, B R ^a   Zangwill, K M ^a   Palmer, C S ^a   Mendelman, P M ^a   Yan, L ^a   Wolff, M C ^a   Cho, I ^a   Marcy, S M ^a   Iacuzio, D ^a   Belshe, R B ^a  

^a UNITED BIOSOURCE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DOUBLE BLIND PROCEDURE; DRUG COST; ECONOMICS; HEALTH CARE COST; HEALTH SERVICE; HUMAN; INFANT; INFLUENZA; INTRANASAL DRUG ADMINISTRATION; MULTICENTER STUDY; PRESCHOOL CHILD; PRODUCTIVITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICS; UTILIZATION REVIEW; VACCINATION;

ADMINISTRATION, INTRANASAL; CHILD, PRESCHOOL; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; DRUG COSTS; EFFICIENCY; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; PLACEBOS; PROSPECTIVE STUDIES; VACCINATION;

MLCS; MLOWN;

EID: 0035430669     PISSN: None     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.108.2.e24     Document Type: Article

References (0)